MIDIANA ZILNIC 3mg / 0.03mg film-coated tablets medication leaflet

G03AA12 drospirenone + ethinylestradiol • Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations

The combination of Drospirenonum + Etinilestradiolum is used as an oral contraceptive for the prevention of pregnancy and for the treatment of moderate acne in women seeking oral contraception. Drospirenonum is a progestin, and Etinilestradiolum is a synthetic estrogen; together, they work to prevent ovulation and alter the uterine lining.

The medication is taken orally, usually once daily, according to a specific regimen. It is effective in preventing pregnancy and improving acne symptoms.

Side effects may include nausea, headache, weight changes, breast tenderness, and, in rare cases, thromboembolism. Regular monitoring is recommended during use.

Consult your doctor to discuss the benefits and risks of using this combination. Follow the administration instructions to ensure contraceptive effectiveness.

General data about MIDIANA ZILNIC 3mg / 0.03mg

Substance: drospirenone + ethinylestradiol

Date of last drug list: 01-01-2015

Commercial code: W61180002

Concentration: 3mg / 0.03mg

Pharmaceutical form: film-coated tablets

Quantity: 84

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: GEDEON RICHTER PLC. - UNGARIA

Holder: GEDEON RICHTER ROMANIA S.A. - ROMANIA

Number: 13856/2021/01

Shelf life: 2 years

Concentrations available for drospirenone + ethinylestradiol

3mg/0.02mg, 3mg/0.030mg, 3mg/0.03mg